AVIR
Price
$3.37
Change
-$0.09 (-2.60%)
Updated
Aug 8, 04:59 PM (EDT)
Capitalization
296.1M
90 days until earnings call
GALT
Price
$4.12
Change
+$0.28 (+7.29%)
Updated
Aug 8, 04:59 PM (EDT)
Capitalization
241.77M
10 days until earnings call
Interact to see
Advertisement

AVIR vs GALT

Header iconAVIR vs GALT Comparison
Open Charts AVIR vs GALTBanner chart's image
Atea Pharmaceuticals
Price$3.37
Change-$0.09 (-2.60%)
Volume$5.45K
Capitalization296.1M
Galectin Therapeutics
Price$4.12
Change+$0.28 (+7.29%)
Volume$4.38K
Capitalization241.77M
AVIR vs GALT Comparison Chart in %
Loading...
AVIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVIR vs. GALT commentary
Aug 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVIR is a Hold and GALT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 09, 2025
Stock price -- (AVIR: $3.46 vs. GALT: $3.82)
Brand notoriety: AVIR and GALT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVIR: 79% vs. GALT: 23%
Market capitalization -- AVIR: $296.1M vs. GALT: $241.77M
AVIR [@Biotechnology] is valued at $296.1M. GALT’s [@Biotechnology] market capitalization is $241.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVIR’s FA Score shows that 0 FA rating(s) are green whileGALT’s FA Score has 0 green FA rating(s).

  • AVIR’s FA Score: 0 green, 5 red.
  • GALT’s FA Score: 0 green, 5 red.
According to our system of comparison, AVIR is a better buy in the long-term than GALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVIR’s TA Score shows that 5 TA indicator(s) are bullish while GALT’s TA Score has 5 bullish TA indicator(s).

  • AVIR’s TA Score: 5 bullish, 4 bearish.
  • GALT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both AVIR and GALT are a good buy in the short-term.

Price Growth

AVIR (@Biotechnology) experienced а -4.95% price change this week, while GALT (@Biotechnology) price change was +4.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.15%. For the same industry, the average monthly price growth was +6.53%, and the average quarterly price growth was +13.35%.

Reported Earning Dates

AVIR is expected to report earnings on Nov 06, 2025.

GALT is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+0.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVIR($296M) has a higher market cap than GALT($242M). GALT YTD gains are higher at: 196.124 vs. AVIR (3.284). GALT has higher annual earnings (EBITDA): -38.92M vs. AVIR (-161.77M). AVIR has more cash in the bank: 425M vs. GALT (7.43M). AVIR has less debt than GALT: AVIR (1.45M) vs GALT (108M). AVIR (0) and GALT (0) have equivalent revenues.
AVIRGALTAVIR / GALT
Capitalization296M242M122%
EBITDA-161.77M-38.92M416%
Gain YTD3.284196.1242%
P/E RatioN/AN/A-
Revenue00-
Total Cash425M7.43M5,719%
Total Debt1.45M108M1%
FUNDAMENTALS RATINGS
AVIR vs GALT: Fundamental Ratings
AVIR
GALT
OUTLOOK RATING
1..100
6224
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
96
Overvalued
PROFIT vs RISK RATING
1..100
9576
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
4834
P/E GROWTH RATING
1..100
94100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVIR's Valuation (40) in the Biotechnology industry is somewhat better than the same rating for GALT (96). This means that AVIR’s stock grew somewhat faster than GALT’s over the last 12 months.

GALT's Profit vs Risk Rating (76) in the Biotechnology industry is in the same range as AVIR (95). This means that GALT’s stock grew similarly to AVIR’s over the last 12 months.

AVIR's SMR Rating (97) in the Biotechnology industry is in the same range as GALT (100). This means that AVIR’s stock grew similarly to GALT’s over the last 12 months.

GALT's Price Growth Rating (34) in the Biotechnology industry is in the same range as AVIR (48). This means that GALT’s stock grew similarly to AVIR’s over the last 12 months.

AVIR's P/E Growth Rating (94) in the Biotechnology industry is in the same range as GALT (100). This means that AVIR’s stock grew similarly to GALT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVIRGALT
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 15 days ago
78%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 19 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
AVIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TIAOF0.490.02
+3.94%
Telecom Italia S.p.A.
VLVLY29.720.85
+2.94%
Volvo AB
SFDL30.64N/A
N/A
Security Federal Corp.
TOMYY29.15N/A
N/A
Tomy Co., Ltd.
PREIF0.06-0.01
-7.71%
Precipitate Gold Corp